Drug information for LENTE INSULIN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 100 UNITS/ML Discontinued   INSULIN ZINC SUSP BEEF Insulin, Long-Acting NOVO NORDISK INC 17998
INJECTABLE; INJECTION 40 UNITS/ML Discontinued   INSULIN ZINC SUSP BEEF Insulin, Long-Acting NOVO NORDISK INC   "

Drug Adverse Effects information for LENTE INSULIN

Role code Indications Reaction # Reports
C ANTICOAGULANT THERAPY APHASIA 3
C ANTICOAGULANT THERAPY COAGULATION TIME PROLONGED 3
C ANTICOAGULANT THERAPY CONVULSION 3
C ANTICOAGULANT THERAPY DIABETES MELLITUS 3
C ANTICOAGULANT THERAPY EPISTAXIS 3
C ANTICOAGULANT THERAPY HEPARIN-INDUCED THROMBOCYTOPENIA 3
C ANTICOAGULANT THERAPY HEPATIC FAILURE 3
C ANTICOAGULANT THERAPY HYPERHIDROSIS 3
C ANTICOAGULANT THERAPY HYPOTENSION 3
C ANTICOAGULANT THERAPY MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 3
C ANTICOAGULANT THERAPY METASTASES TO LUNG 3
C ANTICOAGULANT THERAPY MOBILITY DECREASED 3
C ANTICOAGULANT THERAPY NAUSEA 3
C ANTICOAGULANT THERAPY ORGAN FAILURE 3
C ANTICOAGULANT THERAPY PHARYNGEAL OEDEMA 3
C ANTICOAGULANT THERAPY PULMONARY EMBOLISM 3
C ANTICOAGULANT THERAPY RENAL CELL CARCINOMA 3
C ANTICOAGULANT THERAPY RENAL FAILURE 3
C ANTICOAGULANT THERAPY UNRESPONSIVE TO STIMULI 3
C ANTICOAGULANT THERAPY VOMITING 3
C CONVULSION APHASIA 1
C CONVULSION COAGULATION TIME PROLONGED 1
C CONVULSION CONVULSION 1
C CONVULSION DIABETES MELLITUS 1
C CONVULSION EPISTAXIS 1
C CONVULSION HEPARIN-INDUCED THROMBOCYTOPENIA 1
C CONVULSION HEPATIC FAILURE 1
C CONVULSION HYPERHIDROSIS 1
C CONVULSION HYPOTENSION 1
C CONVULSION MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
C CONVULSION METASTASES TO LUNG 1
C CONVULSION MOBILITY DECREASED 1
C CONVULSION NAUSEA 1
C CONVULSION ORGAN FAILURE 1
C CONVULSION PHARYNGEAL OEDEMA 1
C CONVULSION PULMONARY EMBOLISM 1
C CONVULSION RENAL CELL CARCINOMA 1
C CONVULSION RENAL FAILURE 1
C CONVULSION UNRESPONSIVE TO STIMULI 1
C CONVULSION VOMITING 1
C PRODUCT USED FOR UNKNOWN INDICATION APHASIA 18
C PRODUCT USED FOR UNKNOWN INDICATION COAGULATION TIME PROLONGED 18
C PRODUCT USED FOR UNKNOWN INDICATION CONVULSION 18
C PRODUCT USED FOR UNKNOWN INDICATION DIABETES MELLITUS 18
C PRODUCT USED FOR UNKNOWN INDICATION EPISTAXIS 18
C PRODUCT USED FOR UNKNOWN INDICATION HEPARIN-INDUCED THROMBOCYTOPENIA 18
C PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FAILURE 18
C PRODUCT USED FOR UNKNOWN INDICATION HYPERHIDROSIS 18
C PRODUCT USED FOR UNKNOWN INDICATION HYPOTENSION 18
C PRODUCT USED FOR UNKNOWN INDICATION MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 18
C PRODUCT USED FOR UNKNOWN INDICATION METASTASES TO LUNG 18
C PRODUCT USED FOR UNKNOWN INDICATION MOBILITY DECREASED 18
C PRODUCT USED FOR UNKNOWN INDICATION NAUSEA 18
C PRODUCT USED FOR UNKNOWN INDICATION ORGAN FAILURE 18
C PRODUCT USED FOR UNKNOWN INDICATION PHARYNGEAL OEDEMA 18
C PRODUCT USED FOR UNKNOWN INDICATION PULMONARY EMBOLISM 18
C PRODUCT USED FOR UNKNOWN INDICATION RENAL CELL CARCINOMA 18
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE 18
C PRODUCT USED FOR UNKNOWN INDICATION UNRESPONSIVE TO STIMULI 18
C PRODUCT USED FOR UNKNOWN INDICATION VOMITING 18
C PULMONARY EMBOLISM APHASIA 3
C PULMONARY EMBOLISM COAGULATION TIME PROLONGED 3
C PULMONARY EMBOLISM CONVULSION 3
C PULMONARY EMBOLISM DIABETES MELLITUS 3
C PULMONARY EMBOLISM EPISTAXIS 3
C PULMONARY EMBOLISM HEPARIN-INDUCED THROMBOCYTOPENIA 3
C PULMONARY EMBOLISM HEPATIC FAILURE 3
C PULMONARY EMBOLISM HYPERHIDROSIS 3
C PULMONARY EMBOLISM HYPOTENSION 3
C PULMONARY EMBOLISM MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 3
C PULMONARY EMBOLISM METASTASES TO LUNG 3
C PULMONARY EMBOLISM MOBILITY DECREASED 3
C PULMONARY EMBOLISM NAUSEA 3
C PULMONARY EMBOLISM ORGAN FAILURE 3
C PULMONARY EMBOLISM PHARYNGEAL OEDEMA 3
C PULMONARY EMBOLISM PULMONARY EMBOLISM 3
C PULMONARY EMBOLISM RENAL CELL CARCINOMA 3
C PULMONARY EMBOLISM RENAL FAILURE 3
C PULMONARY EMBOLISM UNRESPONSIVE TO STIMULI 3
C PULMONARY EMBOLISM VOMITING 3
Ads by Google